SCHEMBL5199523

SCHEMBL5199523

CC(CC1OC(SC(C)(C)C)C(O)C(O)C1O)C(N)=O

nearest known ligand 0.39

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
LGALS3 P17931 6/20 0.36
LGALS1 P09382 2/20 0.33
LGALS9 O00182 1/20 0.33
LGALS8 O00214 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5199046 0.84 LGALS3 (0.38) LGALS3LGALS1LGALS9LGALS8
SCHEMBL5198276 0.82 LGALS3 (0.38) LGALS3LGALS1LGALS9LGALS8
SCHEMBL5633189 0.80 LGALS3 (0.34) LGALS3LGALS1LGALS9LGALS8
SCHEMBL5197001 0.75 PYGB (0.41) LGALS3LGALS1LGALS9LGALS8
SCHEMBL23266363 0.73 LGALS3 (0.62) LGALS3LGALS1LGALS9LGALS8
SCHEMBL15723575 0.73 LGALS3 (0.62) LGALS3LGALS1LGALS9LGALS8
SCHEMBL5197120 0.73 IDUA (0.36)
SCHEMBL5198747 0.73 IDUA (0.36) LGALS3
SCHEMBL5197875 0.72 IDUA (0.33)
SCHEMBL4869132 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1814893-A2 NOVEL LINCOMYCIN DERIVATIVES POSSESSING ANTIBACTERIAL ACTIVITY Vicuron Pharmaceuticals, Inc. (US) 2007-08-08 EP disclosed
WO-2006055070-A2 NOVEL LINCOMYCIN DERIVATIVES POSSESSING ANTIBACTERIAL ACTIVITY VICURON PHARMACEUTICALS INC. (US) 2006-05-26 WO disclosed
EP-1644393-A2 NOVEL LINCOMYCIN DERIVATIVES POSSESSING ANTIMICROBIAL ACTIVITY Vicuron Pharmaceuticals, Inc. (US) 2006-04-12 EP disclosed
WO-2005012320-A2 NOVEL LINCOMYCIN DERIVATIVES POSSESSING ANTIMICROBIAL ACTIVITY VICURON PHARMACEUTICALS, INC. (US) 2005-02-10 WO disclosed